Curcumin Bio

Curcumin Bio

$31.40
RV30B

Curcumin Bio is a practitioner-only listed medicine containing curcumin combined with soy lecithin-derived phospholipids, including phosphatidyl choline. It is intended for qualified healthcare practitioners seeking curcumin-based support for inflammation relief and antioxidant activity.

60 x 500 mg capsules | AUST L 219892

Each 500 mg capsule contains:

Curcumin 350 mg

Soy phosphatidylserine-enriched soy lecithin powder 150 mg
Equivalent to phosphatidyl choline 35 mg
Equivalent to soy phosphatidylserine 1.5 mg

Contains soya bean products.

Curcumin Bio is formulated to:

  • relieve inflammation
  • provide antioxidant activity
  • help reduce free radicals formed in the body

Directions

Recommended practitioner dosage:

Take 1 capsule twice daily with food, or as directed by a qualified healthcare practitioner.

For ongoing practitioner-directed support, 1 capsule daily may be used where appropriate.

Dosage and duration should be determined by the treating healthcare practitioner based on individual assessment.

Warnings

Adults only

Contains soya bean products.

If symptoms persist, talk to your health professional.

In very rare cases, Curcumin may harm the liver. Stop use and see a doctor if you have yellowing skin or eyes, or unusual fatigue, nausea, appetite loss, abdominal pain, dark urine or itching.

This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level and pathway-level research relating to curcumin, phospholipid delivery and antioxidant / inflammatory pathways. It does not represent additional ARTG indications for Curcumin Bio.

Curcumin Bio is relevant to practitioners interested in curcumin research, inflammatory pathway modulation, oxidative stress, antioxidant activity, cellular signalling and phospholipid-based delivery systems.

Curcumin has been widely discussed in professional literature in relation to inflammatory signalling, oxidative stress, antioxidant activity and cellular pathway research. Recent review literature continues to examine curcumin and curcumin analogues in relation to antioxidant, anti-inflammatory and other biological activities.

Curcumin is also recognised for formulation challenges relating to absorption and bioavailability. Curcumin Bio combines curcumin with soy lecithin-derived phospholipids, including phosphatidyl choline, which is relevant to practitioner education around phospholipid-associated curcumin delivery and cellular bioavailability research.

The formula’s curcumin content supports practitioner interest in inflammation relief and antioxidant activity, while the soy phospholipid component supports discussion of delivery-system design and ingredient functionality.

Practitioners should also be aware that medicinal turmeric and curcumin products have been associated with a rare risk of liver injury. This safety consideration is relevant when assessing suitability, duration of use and patient monitoring.

This information is provided for practitioner education only and does not represent additional ARTG indications for Curcumin Bio.

References available to registered practitioners on request.